Thursday, February 19, 2026 at 12:31 PM
Hims & Hers Health has agreed to acquire digital health company Eucalyptus in a deal valued at $1.15 billion in an effort to expand its geographic reach.
The telehealth platform expects its growth to continue this year, though its first-quarter guidance came in short of Wall Street’s expectations.
The Australian logistics operator has agreed to support a takeover offer from a consortium led by Macquarie Asset Management that values its equity at $6.51 billion.
The medical-device maker is expected to operate as a stand-alone company within Danaher’s Diagnostics segment.
Gilead Sciences has agreed to buy the rest of development partner Arcellx in a deal that values the biotechnology company at about $7.8 billion at closing.
Data sourced from public RSS feeds and News APIs.
